Impact of Prior Clinical Information in an EHR on Care Outcomes of Emergency ...Nawanan Theera-Ampornpunt
Theera-Ampornpunt N, Speedie SM, Du J, Park YT, Kijsanayotin B, Connelly DP. Impact of prior clinical information in an EHR on care outcomes of emergency patients. Paper presented at: Biomedical and Health Informatics - From Foundations to Applications to Policy. AMIA 2009 Annual Symposium; 2009 Nov 14-18; San Francisco, CA.
Based on Theera-Ampornpunt N, Speedie SM, Du J, Park YT, Kijsanayotin B, Connelly DP. Impact of prior clinical information in an EHR on care outcomes of emergency patients. AMIA Annu Symp Proc. 2009 Nov:634-8. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2815461/
Shared decision making - making it work by Dr Peter SaulSMACC Conference
Who decides? For thousands of years, doctor knew best, but recently respect for patient autonomy has emerged as a key ethical principle in decision making. This has led to the suggestion that decisions should be shared between patients, families and the medical team. An international consensus conference embraced this model for end of life decision making in ICU. But what is shared decision making, does it improve outcomes and is it legally safe? This podcast suggests that the answer so far is a definite maybe.
Imogen Mitchell - Morphing the Recalcitrant ClinicianSMACC Conference
Imogen Mitchell’s SMACC Chicago talk 'Morphing the Recalcitrant Clinician’ talks us through the steps to engage the reluctant physician when implementing change.
Imogen initally touches on the stages of physician engagement from aversion, to apathy, to engaged and then outlines the steps to morphing the reluctant physician.
1. Seek out a clinical champion
2. Establish a common purpose/vision
3. Standardise what is standardisable
4. Communication, communication, communication
5. Work out barriers and overcome them
6. Deal with the ‘Whats in it for me?’WIFM
Impact of Prior Clinical Information in an EHR on Care Outcomes of Emergency ...Nawanan Theera-Ampornpunt
Theera-Ampornpunt N, Speedie SM, Du J, Park YT, Kijsanayotin B, Connelly DP. Impact of prior clinical information in an EHR on care outcomes of emergency patients. Paper presented at: Biomedical and Health Informatics - From Foundations to Applications to Policy. AMIA 2009 Annual Symposium; 2009 Nov 14-18; San Francisco, CA.
Based on Theera-Ampornpunt N, Speedie SM, Du J, Park YT, Kijsanayotin B, Connelly DP. Impact of prior clinical information in an EHR on care outcomes of emergency patients. AMIA Annu Symp Proc. 2009 Nov:634-8. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2815461/
Shared decision making - making it work by Dr Peter SaulSMACC Conference
Who decides? For thousands of years, doctor knew best, but recently respect for patient autonomy has emerged as a key ethical principle in decision making. This has led to the suggestion that decisions should be shared between patients, families and the medical team. An international consensus conference embraced this model for end of life decision making in ICU. But what is shared decision making, does it improve outcomes and is it legally safe? This podcast suggests that the answer so far is a definite maybe.
Imogen Mitchell - Morphing the Recalcitrant ClinicianSMACC Conference
Imogen Mitchell’s SMACC Chicago talk 'Morphing the Recalcitrant Clinician’ talks us through the steps to engage the reluctant physician when implementing change.
Imogen initally touches on the stages of physician engagement from aversion, to apathy, to engaged and then outlines the steps to morphing the reluctant physician.
1. Seek out a clinical champion
2. Establish a common purpose/vision
3. Standardise what is standardisable
4. Communication, communication, communication
5. Work out barriers and overcome them
6. Deal with the ‘Whats in it for me?’WIFM
Course 2 the need for a careful and thorough historyNelson Hendler
The medical literature reports that 40%-80% of chronic pain patients are misdiagnosed. Clearly, misdiagnosis leads to ordering the wrong tests, and thereby obtaining an incorrect diagnosis, or overlooking a diagnosis totally, which results in mistreatment. Many reports in the medical literature indicate the best way to get an accurate diagnosis, is to obtain a complete and thorough history. However, this is a time consuming process, and most physicians don’t spend the needed time with a patient. Therefore, a team of doctors from Johns Hopkins Hospital developed a 72 question test, with 2008 possible answers, available over the Internet. When a patient completes the questionnaire, diagnoses are returned within 5 minutes. These diagnoses have a 96% correlation with diagnoses of Johns Hopkins Hospital doctors. This is the highest level of accuracy of any expert system available. The efficacy of this approach is proven by outcome studies, which prove that this approach results in a far higher return to work rate and reduced use of medication and doctors visits, when compared to other techniques. This is similar to the techniques used by Johns Hopkins Hospital to reduce their workers compensation payments by 54%.
Genomic investigations often produce more information than is initially expected. Several documents have addressed this issue. While the approaches to the management of incidental findings (IFs) vary, it is usually recommended that the information be disclosed if there is clinical utility and the possibility of prevention or treatment. This leaves unsolved fundamental issues such as the different ways of interpreting clinical utility and countless sources of uncertainty. Guidelines can offer indications but should not be allowed to relieve healthcare professionals of their responsibilities.
Screening for diseases from community medicine. It explains the definition of screening, lead time, uses of screening, differences between screening and diagnostic test, criteria for a disease to be screened and criteria for a screening test, cut-off points, etc
SHARE Webinar: Why Should I Join a Clinical Trial with Dr. Hershmanbkling
Dr. Dawn L. Hershman of the Herbert Irving Comprehensive Cancer Center at Columbia University presented the basics of clinical trials and emphasized how important it is for more patients to participate in them. She also discussed trials currently available for early stage and metastatic breast cancers. The webinar was presented on June 25, 2014. To hear the webinar, visit www.sharecancersupport.org/hershman
Carle Palliative Care Journal Club 1/15/2020Mike Aref
A journal club review and criticism of J Natl Cancer Inst. 2019 Dec 17. pii: djz233. doi: 10.1093/jnci/djz233 Emergency Department Visits for Opioid Overdoses Among Patients with Cancer by Jairam V, Yang DX, Yu JB, Park HS.
Screening for disease or Early detection of disease is detecting a disease at an earlier stage than would usually occur in standard clinical practice.
This denotes detecting disease at a pre-symptomatic stage, at which point the patient has no clinical complaint ( no symptoms or signs) and therefore no reason to seek medical care for the condition
Early detection of disease is beneficial and that intervention at an earlier stage of the disease process is more effective or easier to implement than a later intervention
Palliative care is about providing well-being and the highest quality of life to patients with serious, progressive, chronic life-limiting illness, including during the dying process.
Do Not Resuscitate Orders : What They Mean ?SMSRAZA
Most doctors working in Acute areas know when and how to do CPR. However, most get stuck when it comes to ' When not to do CPR' due to cultural, social, ethical and legal issues attached.
Course 2 the need for a careful and thorough historyNelson Hendler
The medical literature reports that 40%-80% of chronic pain patients are misdiagnosed. Clearly, misdiagnosis leads to ordering the wrong tests, and thereby obtaining an incorrect diagnosis, or overlooking a diagnosis totally, which results in mistreatment. Many reports in the medical literature indicate the best way to get an accurate diagnosis, is to obtain a complete and thorough history. However, this is a time consuming process, and most physicians don’t spend the needed time with a patient. Therefore, a team of doctors from Johns Hopkins Hospital developed a 72 question test, with 2008 possible answers, available over the Internet. When a patient completes the questionnaire, diagnoses are returned within 5 minutes. These diagnoses have a 96% correlation with diagnoses of Johns Hopkins Hospital doctors. This is the highest level of accuracy of any expert system available. The efficacy of this approach is proven by outcome studies, which prove that this approach results in a far higher return to work rate and reduced use of medication and doctors visits, when compared to other techniques. This is similar to the techniques used by Johns Hopkins Hospital to reduce their workers compensation payments by 54%.
Genomic investigations often produce more information than is initially expected. Several documents have addressed this issue. While the approaches to the management of incidental findings (IFs) vary, it is usually recommended that the information be disclosed if there is clinical utility and the possibility of prevention or treatment. This leaves unsolved fundamental issues such as the different ways of interpreting clinical utility and countless sources of uncertainty. Guidelines can offer indications but should not be allowed to relieve healthcare professionals of their responsibilities.
Screening for diseases from community medicine. It explains the definition of screening, lead time, uses of screening, differences between screening and diagnostic test, criteria for a disease to be screened and criteria for a screening test, cut-off points, etc
SHARE Webinar: Why Should I Join a Clinical Trial with Dr. Hershmanbkling
Dr. Dawn L. Hershman of the Herbert Irving Comprehensive Cancer Center at Columbia University presented the basics of clinical trials and emphasized how important it is for more patients to participate in them. She also discussed trials currently available for early stage and metastatic breast cancers. The webinar was presented on June 25, 2014. To hear the webinar, visit www.sharecancersupport.org/hershman
Carle Palliative Care Journal Club 1/15/2020Mike Aref
A journal club review and criticism of J Natl Cancer Inst. 2019 Dec 17. pii: djz233. doi: 10.1093/jnci/djz233 Emergency Department Visits for Opioid Overdoses Among Patients with Cancer by Jairam V, Yang DX, Yu JB, Park HS.
Screening for disease or Early detection of disease is detecting a disease at an earlier stage than would usually occur in standard clinical practice.
This denotes detecting disease at a pre-symptomatic stage, at which point the patient has no clinical complaint ( no symptoms or signs) and therefore no reason to seek medical care for the condition
Early detection of disease is beneficial and that intervention at an earlier stage of the disease process is more effective or easier to implement than a later intervention
Palliative care is about providing well-being and the highest quality of life to patients with serious, progressive, chronic life-limiting illness, including during the dying process.
Do Not Resuscitate Orders : What They Mean ?SMSRAZA
Most doctors working in Acute areas know when and how to do CPR. However, most get stuck when it comes to ' When not to do CPR' due to cultural, social, ethical and legal issues attached.
What is a dysphagia? What are the latest trends to deal with the case who has presented to you? This "Seminar Presentation" list some of the latest American College of Surgery guidelines, regarding the management of a case of dysphagia
A presentation made by Dr Gauhar Mahmood Azeem on the interpretations of a simple CBC and the information it can give us, Various conditions which may cause derangement are mentioned,
Iv fluid therapy (types, indications, doses calculation)kholeif
All what you need to know intravenous fluids, types, indications, contraindications, how to calculate fluid rate and drug dosages.
Embed code (http://www.slideshare.net/slideshow/embed_code/16138690)
Presentation by Dr Sheila Carey - Arrowe Park Hospital at the Regional Emergency Laparotomy Collaborative - Complex decision making collaborative at Arrowe Park Hospital on 24 January 2020.
Good Clinical Practice is a part of pharmaceutical quality assurance in pharmaceutical industry and its about the clinical trials of drugs for patients .
New drug research starts by studying how the body functions at its most basic levels. The first series of tests
Presented in:
Pre-Conference Workshop on Communication Skills in Management of Cancer Patients,
World Cancer Day Conference & Expo 2015
by National Cancer Society of Malaysia
Hospice care and palliative care: Is there a difference between the two, and if so, what?
Many people still think that palliative care means hospice care. But today, hospice is only a small part of palliative care.
The goal of palliative care is to prevent or treat the symptoms and side effects of a disease; and it should be part of the picture from the first day a serious illness is diagnosed.
Dr. Jim Meadows, Director of Hospice and Palliative Care at Tennessee Oncology, will discuss this important topic. How does a family and a health care team best work together to guide a patient through a terminal illness? How does everyone continue to support quality, patient-centered, end-of-life care?
I didn't know this option of Palliative care existed prior to my mother's passing earlier this year of colorectal cancer. However, I do now know about it and want to share it with all of you
Matt Anstey is an intensivist from Sir Charles Gardiner hospital in Perth, Australia.
He gave this talk on outcomes after intensive care at an ICN WA meeting in Perth last year.
How do we deliver on palliative care aspirations at the end of life in the acute setting?
Jean Clark, Karen Sheward, Joy Percy, Celine Collins, Simon Allan
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
CDSCO and Phamacovigilance {Regulatory body in India}NEHA GUPTA
The Central Drugs Standard Control Organization (CDSCO) is India's national regulatory body for pharmaceuticals and medical devices. Operating under the Directorate General of Health Services, Ministry of Health & Family Welfare, Government of India, the CDSCO is responsible for approving new drugs, conducting clinical trials, setting standards for drugs, controlling the quality of imported drugs, and coordinating the activities of State Drug Control Organizations by providing expert advice.
Pharmacovigilance, on the other hand, is the science and activities related to the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problems. The primary aim of pharmacovigilance is to ensure the safety and efficacy of medicines, thereby protecting public health.
In India, pharmacovigilance activities are monitored by the Pharmacovigilance Programme of India (PvPI), which works closely with CDSCO to collect, analyze, and act upon data regarding adverse drug reactions (ADRs). Together, they play a critical role in ensuring that the benefits of drugs outweigh their risks, maintaining high standards of patient safety, and promoting the rational use of medicines.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMSAkankshaAshtankar
MIP 201T & MPH 202T
ADVANCED BIOPHARMACEUTICS & PHARMACOKINETICS : UNIT 5
APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS By - AKANKSHA ASHTANKAR
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
Basavarajeeyam is a Sreshta Sangraha grantha (Compiled book ), written by Neelkanta kotturu Basavaraja Virachita. It contains 25 Prakaranas, First 24 Chapters related to Rogas& 25th to Rasadravyas.
The Gram stain is a fundamental technique in microbiology used to classify bacteria based on their cell wall structure. It provides a quick and simple method to distinguish between Gram-positive and Gram-negative bacteria, which have different susceptibilities to antibiotics
Rethinking DNACPR orders: ethical issues and a proposal for change - Fritz
1. Rethinking DNACPR orders:
ethical issues
and a proposal for change
Dr. Zoë Fritz
Wellcome Fellow in Bioethics
Consultant Physician, Acute Medicine
2. Current use In Hospitals
• 80% of those who die in hospital die with one in
place
• Majority initiated by clinicians
• 50% of patients with DNACPR in hospital are
discharged home.
• In the front of notes, often red – problems exist
with current approach
Fritz ZB et al. Characteristics and outcome of patients with DNACPR orders in an acute hospital; an
observational study. Resuscitation 85 (2014) 104–108
3. Q1: How often do you go to assess a
patient
(excluding post arrest patients)
who has been referred to ICU and think
they should have a DNACPR order?
A. Never
B. Once a shift
C. Once a week on the unit
D. Once a year
E. Once in a blue moon Never
Once
a
shift
Once
a
w
eekon
the
unit
Once
a
year
Once
in
a
blue
m
oon
1%
43%
1%2%
53%
4. Issue 1 : Not routinely completed
• Qualitative study Cohn et al Q J Med 2013; 106:165–177
• Completed on an ad hoc basis
• NCEPOD report
• 430/522 (78%) of patients had no resuscitation status decision
documented
• 7/573 patients who underwent CPR were on an end of life care
pathway
8. Q2: How often have you gone to a patient
who has survived an attempted
resuscitation attempt, and not admitted
them to ICU because you don’t think they
would benefit.
A. Never
B. Once a shift
C. Once a week on the unit
D. Once a year
E. Once in a blue moon Never
Once
a
shift
Once
a
w
eekon
the
unit
Once
a
year
Once
in
a
blue
m
oon
1%
8%
4%
35%
52%
9. Issue 2 : Inappropriate resuscitation
attempts
• NCEPOD: 118/202
patients who had survived
resuscitation were not
admitted to ICU
10. Ethical implication:
• Receiving unwanted treatments at the end
of life
• Perceived ‘undignified’ death
• Resources being used to no (or negative)
effect
11. Q3: How often do you wish a nice, calm conversation
had been had with a patient and their family in advance
about what they would and wouldn’t want in the event
of their deterioration, and it was all beautifully
documented?
A. Never
B. Once a shift
C. Once a week on the unit
D. Once a year
E. Once in a blue moon
Never
Once
a
shift
Once
a
w
eekon
the
unit
Once
a
year
Once
in
a
blue
m
oon
2%
59%
2%4%
33%
12. Issue 3: No one likes discussing this
• Patients rarely initiate discussions, doctors don’t like to
have discussions
• In 2012 50% discussed with patients or relatives
Fritz ZB et al. Characteristics and outcome of patients with DNACPR orders in an acute hospital; an
observational study. Resuscitation 85 (2014) 104–108
• Recent judgments have made in illegal not to discuss a
decision to withhold CPR…
13. Tracey
• Must discuss unless you think it would cause physiological
or psychological harm – to not do so would be in breach of
article 8 of Human Rights Act
• If you don’t tell a patient that you have made a decision,
you are depriving them of the right to question it, and the
right to ask for a second opinion
• This extends to other treatments as well
• Other areas of non disclosure to be challenged?
• R(Tracey) v Cambridge University Hospital NHS FT and others [2014] EWCA Civ 822 )
14. Winspear
• If a patient does not have capacity:
• Don’t make a ‘holding decision’ and wait ‘til the morning
• As long as it is ‘practicable and appropriate’ call someone who
knows them
Winspear v City Hospitals Sunderland NHS FT
[2015] EWHC 3250 (QB)
15. Burke still stands
• The patient still does not have the right to
demand a clinical treatment that is not
considered in their interests
• They do have a right
• to know that that a decision has been made and
• to question it
16. Ethical implications..
• Focus has been on patients having DNACPR ‘without
knowledge’ and the issues associated with this –
autonomy, right to private life, etc
• Some patients anxious about being resuscitated; not
talking with them about DNACPR may cause as much
more distress
(in preparation, A Malyon)
17. Issue 4: Misunderstood
• Less frequently referred to outreach or receive out of
hours care
Interpretation and intent: A study of the (mis)understanding of DNAR orders in
a teaching hospital Z Fritz et al Resuscitation 2010 81;9: 1138-1141
• Reduction in the urgency attached to reviewing a
deteriorating patient.
The over-interpretation of DNAR Stewart, M. et al Clin Gov 2011 16;2:119-128
• Most common reason for no DNACPR in NCEPOD “Full
and active management” 76.9%
18. Issue 5: Difference in care
• Chen – reduction in treatment for heart failure
Chen JL, et al (2008) Impact of do-not resuscitate orders on quality of care performance
measures in patients hospitalized with acute heart failure. Am Heart J 156: 78–84.
• Cohen – best predictor of not being admitted to
ICU
Cohen RI, et al(2009) The impact of donot-resuscitate order on triage decisions to a
medical intensive care unit. J Crit Care 24: 311–5.
• Kazaure – increased mortality in surgical patients
Kazaure H, et al (2011) High mortality in surgical patients with
do-not-resuscitate orders: analysis of 8256 patients. Arch Surg 146: 922–8.
• Beach and Henneman – scenario experiments
Henneman EA et al(1994) Effect of do not-resuscitate orders on the nursing care of
critically ill patients. Am J Crit Care 3: 467–72.
Beach MC et al (2002) The effect of do-not-resuscitate orders on physician decision-
making. J Am Geriatr Soc 50: 2057–61.
19. Ethical Implication…
• Discrimination, lack of equity
..and feeds into all of the above:
• Reluctance to write them
• Reluctance to talk about them
• How much information you give a patient
20. We tried to address the ethical
problems we saw in current
DNACPR practice in hospitals.
21. Aims of an alternative approach
• Remove the ad hoc nature of consideration
• Improve discussions
• Improve care for those in whom a decision not to
resuscitate had been made
• Remove ‘resus’ labeling
• Shift dichotomy to goals of care
• Encourage forward thinking
• Provide instruction if a patient deteriorates
• Maintain clarity about resuscitation
22. Universal Form of Treatment Options
(UFTO) development
• Designed iteratively using adapted delphi method
• Focus groups, interviews, questionnaires, feedback
• with
• Patients
• Nurses
• Doctors
• Resuscitation officers
• Behavioural economist
23.
24. Assessment of UFTO
• Before and after study
• Contemporaneous case controls
• One hospital, Non-randomised, but outcomes were
blinded…
• Fritz Z, et al. (2013) The Universal Form of Treatment Options (UFTO) as an
Alternative to Do Not Attempt Cardiopulmonary Resuscitation (DNACPR) Orders: A
Mixed Methods Evaluation of the Effects on Clinical Practice and Patient Care. PLoS
ONE 8(9): e70977. doi:10.1371/journal.pone.0070977
http://www.plosone.org/article/info:doi/10.1371/journal.pone.0070977
25. GlobalTriggerToolAnalysison thosepatientsin whoma
decisionnotto attemptresuscitationwasmade
DNAR period
(May-July 2010)
n = 103
UFTO period
(Nov 2010-Jan ‘11)
n = 118
Between group
difference
(95% CI)
P-value§
Harm rate
per 100 admissions
68.9 37.3
31.6
(12.2 to 51.1)
0.001
Harm rate
per 1000 patient days
34.7 21.8
12.9
(2.6 - 23.2)
0.01
Harms contributing to patient
death
(categories H and I)
23/71 (32%) 4/44 (9.1%)
23.3%
(7.8% to 36.1%)
0.006
Harms preventable on any level
(categories 2-4)
66/71 (93%) 43/44 (98%)
-4.8%
(-13.4% to 5.6%) 0.40
§P-value calculated using Fisher’s Exact test for categorical variables, and a z-test for rates
26. Summary of UFTO changes
• Change in culture
• Change in reasoning and nature of discussions
• Earlier recognition of palliative care needs
• Reduction in objective harms occurring to those who were
not for attempted resuscitation
27. Other national and international work
• Treatment Escalation Plan in Devon – M. Mercer et al
• ‘Deciding Right’ in the North East – C. Regnard et al
• ‘Unwell Patient’ S. Guglani, D Gabbot
• ‘Collaborative Child and Young Person’s Advance Care
Plan Group.’
• ‘Physician Orders for Life Sustaining treatment’ in the US
• Review of current practice and problems – systematic
review and other work - G. Perkins et al
28. Emergency Care and Treatment Plan
• Co-Chaired by the Resus council and the RCN
• Stakeholders from all clinical specialties, paramedics,and
patient and public groups
• Iterative process
• Using available evidence
29. The following treatment plan should be used as clinical guidance and is not a substitute for ongoing
consultation and shared decision-making wherever possible. The clinician should initial ONE of the
patient’s priority boxes below, add relevant guidance in the large box and initial a CPR decision.
The form must be signed, named and dated on the reverse.
Name:
Date of Birth: Hospital/NHS numbers:
Address:
1
This individual is FOR attempted
CARDIOPULMONARY RESUSCITATION
Signature…………………………………… 6
This individual is NOT FOR attempted
CARDIOPULMONARY RESUSCITATION
Signature……………………………………
If the patient dies in transit please take to: 6
Please provide clinical guidance on specific interventions that may or may not be wanted or
clinically appropriate in community, hospital and critical care settings:
Provide details of other relevant care planning documents and/or documented wishes about
organ/tissue donation (name and where held):
5
The priority is to get better.
Please consider all treatment
to prolong life
Initials: ..……………………. 4
The priority is to achieve a
balance between getting
better and ensuring good
quality of life. Please consider
selected treatments
Initials: ..…………………… 4
The priority is comfort. Please
consider all treatments aimed
at symptom control
Initials: ..…………………… 4
Turn%over%to%complete%this%ECTP%
Relevant information about the individual’s diagnosis, situation, ability to communicate, and reasons for the
chosen plan.
3
Emergency Care &
Treatment Plan
!
3!
Date: __/__/____
2
30. Designation -
(Grade and specialty)
Print name & professional
registration number
Signature Date and time
Senior Responsible Clinician 10
Plan review: If the individual’s condition changes (i.e. deterioration OR improvement) review the decisions
on this ECTP. Document further conversations in box 8. If necessary, complete a new form, and write
“CANCELLED” clearly across both sides of this form with signature and date. The decisions on this form
should be reviewed specifically before any procedure during which abrupt deterioration or cardiac arrest
may occur (e.g. endoscopy, cardiac pacing, angiography, surgery or anaesthesia). Make an agreed plan on
whether or not to revoke temporarily the decisions on this form and, if so, on the treatments that will be
considered if abrupt deterioration or cardiac arrest occurs. 11
Emergency contacts Name Telephone numbers Other relevant details
Welfare Attorney, Guardian etc
Family/friend
GP
Lead Consultant
Specialist worker/key worker 12
Does the (adult) individual
have capacity?
(see guidance notes)
7
Yes
No
Do they have a valid advance directive or ADRT?
If so, record details in box 5 7
Do they have a representative with legal authority to make decisions (e.g. Welfare
Attorney, Guardian, person with a Lasting Power of Attorney for Health and Welfare)?
If so, contact them and document details of discussion below 7
These decisions: 1. have been discussed with and agreed with the individual;
or 2. have been made in accordance with capacity law;
or 3. in the case of a child, the person holding parental responsibility/court order.
Date of discussion: __/__/____ Names of those present:
Full documentation of discussion can be found in:
Further conversations occurred on the following dates (state where details are recorded):
8
If there has been no shared decision-making with the individual, no shared decision-making with a
representative with legal authority to make decisions or no best-interests meeting for the individual who
lacks capacity, document a full explanation and a clear plan to address this in the clinical records.
Summarise the reason (e.g. describe any potential to cause harm) here:
9
31. Almost ready for…
• Public consultation
• Usability testing
• Multi-Centre Evaluation
32. ‘Take home messages’
• Do Not Attempt Resuscitation Decisions associated with
problems in initiating, discussing and documenting
decisions, and can have unintended effects
• A new approach, contextualising the resuscitation
decision within overall goals of care has been developed
• Get involved with the consulatative process – may be
coming to a hospital near you soon!
33. Thank you
Patients and staff
NIHR, Wellcome trust
Colleagues in Cambridge and Warwick, the
Reususcitation Council, and all of those working
on the Emergency Care and Treatment Plan
Zoefritz@gmail.com
www.ufto.org
Editor's Notes
Observations suggested that DNACPR completion was ad hoc , and that the form was not regularly completed for all patients for whom CPR might actually be thought inappropriate. For example, while some DNACPR decisions were made during the ward round, as a patient was assessed, this was not the norm. In many instances, it was filled out only when senior doctors became alerted by more junior ones or nursing staff that a patient was ‘going off’ (deteriorating), or if, on a Friday afternoon, a doctor was concerned that the patient’s health might dramatically decline over the weekend. Even this forward planning was not undertaken by all doctors. Speaking with clinicians, the general opinion was that a high proportion of DNACPR forms were completed by out-of-hours staff and such decisions would have been better made by the patient’s own medical team rather than by on-call doctors who may never have seen them before.
Summarise – OK, so we have problems that they are not routinely completed, that there are inappropraite resuscitation attempts,a nd that they are not always discussed. But hteese are problems with the implementation of DNACPR orders, and ones which could perhaps be corrected with some stronlgy worded policies or some legislation….
I am now going to move onto some more profound problems, before looking at solutions
The first of these is that they are misunderstood. And they are misundertood to mean, despite the longer acronym, that DNACPR means